Incidence of adult primary immune thrombocytopenia in England—An update (Englisch)
- Neue Suche nach: Doobaree, Indraraj Umesh
- Neue Suche nach: Conway, Katherine
- Neue Suche nach: Miah, Haroon
- Neue Suche nach: Miah, Atiqa
- Neue Suche nach: Makris, Michael
- Neue Suche nach: Hill, Quentin
- Neue Suche nach: Cooper, Nicola
- Neue Suche nach: Bradbury, Charlotte
- Neue Suche nach: Newland, Adrian
- Neue Suche nach: Provan, Drew
- Neue Suche nach: McDonald, Vickie
- Neue Suche nach: UK adult ITP registry
- Neue Suche nach: Doobaree, Indraraj Umesh
- Neue Suche nach: Conway, Katherine
- Neue Suche nach: Miah, Haroon
- Neue Suche nach: Miah, Atiqa
- Neue Suche nach: Makris, Michael
- Neue Suche nach: Hill, Quentin
- Neue Suche nach: Cooper, Nicola
- Neue Suche nach: Bradbury, Charlotte
- Neue Suche nach: Newland, Adrian
- Neue Suche nach: Provan, Drew
- Neue Suche nach: McDonald, Vickie
- Neue Suche nach: UK adult ITP registry
In:
European Journal of Haematology
;
109
, 3
;
238-249
;
2022
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Incidence of adult primary immune thrombocytopenia in England—An update
-
Beteiligte:Doobaree, Indraraj Umesh ( Autor:in ) / Conway, Katherine ( Autor:in ) / Miah, Haroon ( Autor:in ) / Miah, Atiqa ( Autor:in ) / Makris, Michael ( Autor:in ) / Hill, Quentin ( Autor:in ) / Cooper, Nicola ( Autor:in ) / Bradbury, Charlotte ( Autor:in ) / Newland, Adrian ( Autor:in ) / Provan, Drew ( Autor:in )
-
Erschienen in:European Journal of Haematology ; 109, 3 ; 238-249
-
Verlag:
-
Erscheinungsdatum:01.09.2022
-
Format / Umfang:12 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 109, Ausgabe 3
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 195
-
Issue Information| 2022
- 197
-
Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: Real‐world findings from the International Paroxysmal Nocturnal Hemoglobinuria RegistryHöchsmann, Britta / de Fontbrune, Flore Sicre / Lee, Jong Wook / Kulagin, Alexander D. / Hillmen, Peter / Wilson, Amanda / Marantz, Jing L. / Schrezenmeier, Hubert et al. | 2022
- 205
-
Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studiesKulasekararaj, Austin G. / Griffin, Morag / Langemeijer, Saskia / Usuki, Kensuke / Kulagin, Alexander / Ogawa, Masayo / Yu, Ji / Mujeebuddin, Arshad / Nishimura, Jun‐ichi / Lee, Jong Wook et al. | 2022
- 215
-
Development and validation of the sickle cell stress scale‐adultSmith, Wally R. / McClish, Donna K. / Bovbjerg, Viktor E. / Singh, Harjot K. et al. | 2022
- 226
-
Validation of patient‐reported vaso‐occlusive crisis day as an endpoint in sickle cell disease studiesCoyne, Karin S. / Currie, Brooke M. / Callaghan, Michael / Wyrwich, Kathleen W. / Pease, Sheryl / Baker, Christine L. / Arkin, Steven / Pittman, Debra D. et al. | 2022
- 238
-
Incidence of adult primary immune thrombocytopenia in England—An updateDoobaree, Indraraj Umesh / Conway, Katherine / Miah, Haroon / Miah, Atiqa / Makris, Michael / Hill, Quentin / Cooper, Nicola / Bradbury, Charlotte / Newland, Adrian / Provan, Drew et al. | 2022
- 250
-
Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case–control studyRago, Angela / Annibali, Ombretta / Tomarchio, Valeria / Coppetelli, Ugo / Fazio, Francesca / Cupelli, Luca / Fiorini, Alessia / Piciocchi, Alfonso / Tafuri, Agostino / Caravita di Toritto, Tommaso et al. | 2022
- 257
-
Efficacy of conventional‐dose cytarabine, idarubicin and thioguanine versus intermediate‐dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long‐term results of the prospective randomized nationwide AML‐2003 study by the Finnish Leukemia GroupKolonen, Aarne / Sinisalo, Marjatta / Huhtala, Heini / Rimpiläinen, Johanna / Rintala, Hannele / Sankelo, Marja / Koivunen, Elli / Silvennoinen, Raija / Räty, Riikka / Ruutu, Tapani et al. | 2022
- 271
-
Cell‐free DNA levels are increased in acute graft‐versus‐host diseaseKroeze, Anna / Cornelissen, Anne S. / Pascutti, M. Fernanda / Verheij, Myrddin / Bulder, Ingrid / Klarenbeek, Sjoerd / Ait Soussan, Aicha / Hazenberg, Mette D. / Nur, Erfan / van der Schoot, C. Ellen et al. | 2022
- 282
-
Venous thromboembolism prophylaxis in hospitalized sickle cell disease and sickle cell trait patientsIonescu, Filip / Anusim, Nwabundo / Zimmer, Markie / Jaiyesimi, Ishmael et al. | 2022
- 289
-
Relationship between pancreatic iron overload, glucose metabolism and cardiac complications in sickle cell disease: An Italian multicentre studyPistoia, Laura / Meloni, Antonella / Allò, Massimo / Spasiano, Anna / Messina, Giuseppe / Sorrentino, Francesco / Gamberini, Maria Rita / Ermini, Angela / Renne, Stefania / Fina, Priscilla et al. | 2022
- 298
-
Herpes zoster prophylaxis with low‐dose acyclovir in patients with malignant lymphoma and multiple myeloma treated with autologous stem cell transplantationAbbasov, Emin / Metzner, Bernd / Müller, Thomas H. / Casper, Jochen / Kimmich, Christoph / Petershofen, Eduard K. / Renzelmann, Andrea / Rosien, Bernd / Thole, Ruth / Voß, Andreas et al. | 2022
- 305
-
Generic Lenalidomide: An opportunity to address the balance of administrative burden and drug safetyPatrick, Hannah / Ramasamy, Karthik / Rashid, Sabia et al. | 2022